Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Garay Arpa | SVP Human Health Global Mktg. | May 04 | Option Exercise | 87.10 | 907 | 79,000 | 2,368 | May 05 05:24 PM | Oosthuizen Johannes Jacobus | SVP, U.S. Market | May 04 | Option Exercise | 87.10 | 907 | 79,000 | 14,961 | May 05 05:27 PM | Karachun Rita A | Sr. VP Fince-Global Controller | May 04 | Option Exercise | 87.10 | 949 | 82,658 | 41,429 | May 05 05:19 PM | Klobuchar Michael A | EVP - Chief Strategy Officer | May 04 | Option Exercise | 87.10 | 885 | 77,084 | 15,775 | May 05 05:07 PM | LeCointe-Cephas Lisa | SVP Chief Ethics & Com Officer | May 04 | Option Exercise | 87.10 | 813 | 70,812 | 3,943 | May 05 05:04 PM | LeCointe-Cephas Lisa | SVP Chief Ethics & Com Officer | May 03 | Option Exercise | 87.65 | 452 | 39,618 | 3,285 | May 04 05:58 PM | Litchfield Caroline | EVP & CFO | May 03 | Option Exercise | 87.65 | 773 | 67,753 | 27,799 | May 04 05:54 PM | Li Dean Y | Executive VP & President, MRL | May 03 | Option Exercise | 87.65 | 773 | 67,753 | 16,839 | May 04 05:50 PM | Williams David Michael | EVP,Chief Info&Digital Officer | May 03 | Option Exercise | 87.65 | 427 | 37,427 | 9,410 | May 04 05:44 PM | Karachun Rita A | Sr. VP Fince-Global Controller | May 03 | Option Exercise | 87.65 | 902 | 79,060 | 40,789 | May 04 05:37 PM | Oosthuizen Johannes Jacobus | SVP, U.S. Market | May 03 | Option Exercise | 87.65 | 773 | 67,753 | 14,435 | May 04 05:30 PM | Klobuchar Michael A | EVP - Chief Strategy Officer | May 03 | Option Exercise | 87.65 | 773 | 67,753 | 15,271 | May 04 04:53 PM | Garay Arpa | SVP Human Health Global Mktg. | May 03 | Option Exercise | 87.65 | 773 | 67,753 | 1,682 | May 04 04:45 PM | Garay Arpa | SVP Human Health Global Mktg. | May 03 | Option Exercise | 87.65 | 773 | 67,753 | 1,682 | May 04 04:44 PM | LeCointe-Cephas Lisa | SVP Chief Ethics & Com Officer | May 01 | Option Exercise | 88.69 | 640 | 56,762 | 3,053 | May 03 04:25 PM | Williams David Michael | EVP,Chief Info&Digital Officer | May 01 | Option Exercise | 88.69 | 577 | 51,174 | 9,181 | May 03 04:19 PM | Li Dean Y | Executive VP & President, MRL | May 01 | Option Exercise | 88.69 | 1,061 | 94,100 | 16,589 | May 03 04:21 PM | Litchfield Caroline | EVP & CFO | May 01 | Option Exercise | 88.69 | 866 | 76,806 | 27,453 | May 03 04:22 PM | Karachun Rita A | Sr. VP Fince-Global Controller | May 01 | Option Exercise | 88.69 | 928 | 82,304 | 40,205 | May 03 04:17 PM | Oosthuizen Johannes Jacobus | SVP, U.S. Market | May 01 | Option Exercise | 88.69 | 866 | 76,806 | 14,089 | May 03 04:16 PM | Klobuchar Michael A | EVP - Chief Strategy Officer | May 01 | Option Exercise | 88.69 | 866 | 76,806 | 14,925 | May 03 04:13 PM | Garay Arpa | SVP Human Health Global Mktg. | May 01 | Option Exercise | 88.69 | 866 | 76,806 | 1,156 | May 03 04:11 PM | Williams David Michael | EVP,Chief Info&Digital Officer | Feb 10 | Option Exercise | 76.53 | 1,202 | 91,989 | 7,421 | Feb 14 11:13 AM | FRAZIER KENNETH C | Executive Chair | Nov 09 | Option Exercise | 0.00 | 663,881 | 0 | 1,250,676 | Nov 10 04:06 PM | FRAZIER KENNETH C | Executive Chair | Nov 09 | Sale | 82.26 | 663,881 | 54,611,362 | 586,795 | Nov 10 04:06 PM | Litchfield Caroline | EVP & CFO | Nov 04 | Option Exercise | 0.00 | 22,683 | 0 | 42,449 | Nov 05 04:22 PM | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Nov 04 | Option Exercise | 0.00 | 29,782 | 0 | 146,712 | Nov 05 04:24 PM | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Nov 04 | Sale | 90.40 | 29,782 | 2,692,299 | 116,930 | Nov 05 04:24 PM | Litchfield Caroline | EVP & CFO | Nov 04 | Sale | 91.00 | 18,335 | 1,668,503 | 24,114 | Nov 05 04:22 PM | Karachun Rita A | Sr. VP Fince-Global Controller | Nov 03 | Option Exercise | 0.00 | 25,000 | 0 | 60,799 | Nov 04 04:19 PM | Karachun Rita A | Sr. VP Fince-Global Controller | Nov 03 | Sale | 88.45 | 25,000 | 2,211,215 | 35,799 | Nov 04 04:19 PM | Clyburn Frank | EVP & Pres ? Human Health | Nov 01 | Option Exercise | 0.00 | 39,762 | 0 | 136,857 | Nov 02 06:16 PM | Gerberding Julie L. | EVP, Chief Patient Officer | Nov 01 | Option Exercise | 0.00 | 96,270 | 0 | 135,432 | Nov 03 04:11 PM | Gerberding Julie L. | EVP, Chief Patient Officer | Nov 01 | Sale | 87.91 | 96,270 | 8,462,682 | 39,162 | Nov 03 04:11 PM | Clyburn Frank | EVP & Pres ? Human Health | Nov 01 | Sale | 87.87 | 39,762 | 3,493,879 | 97,095 | Nov 02 06:16 PM | Clyburn Frank | EVP & Pres ? Human Health | Oct 30 | Option Exercise | 88.05 | 2,358 | 207,622 | 98,257 | Nov 02 06:16 PM | MIZELL STEVEN | EVP, Chief HR Officer | Oct 30 | Option Exercise | 88.05 | 4,715 | 415,156 | 27,896 | Nov 02 06:11 PM | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Oct 29 | Option Exercise | 0.00 | 135,405 | 0 | 252,335 | Nov 02 06:12 PM | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Oct 29 | Option Exercise | 0.00 | 24,619 | 0 | 117,764 | Nov 02 06:14 PM | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Oct 29 | Sale | 87.56 | 135,405 | 11,856,265 | 116,930 | Nov 02 06:12 PM | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Oct 29 | Sale | 87.32 | 24,619 | 2,149,731 | 93,145 | Nov 02 06:14 PM |
|